Skip to content
Screener

Debt Repayments at other companies

Insulet logo
InsuletPODD
$0-100%
Medtronic logo
MedtronicMDT
$1.77B
Embecta Corp. logo
Embecta Corp.EMBC
$37.5M+36.9%
AdaptHealth logo
AdaptHealthAHCO
$14.06M-43.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$6.15M-57.3%
Abbott logo
AbbottABT
$1.41B+140,400%

Other financials

Income statement

See full
Revenue$254.6M+5.8%
Gross profit$144.8M+15.0%
Operating income-$13.8M+73.4%
Net income-$21.2M+59.6%
EPS (diluted)-$0.31+60.3%

Balance sheet

See full
Cash & equivalents$62.8M-2.0%
Total debt$739.3M+64.6%
Total equity$130.4M-2.2%
Total assets$1.2B+31.8%

Cash flow

See full
Operating cash flow-$34.6M-265%
CapEx$4.1M-34.7%
Free cash flow-$38.7M-146%

Valuation

See full
Market cap$1.34B+40.1%
Enterprise value$2.02B+50.3%
P/S1.3×+0.3×

Profitability

See full
Gross margin56%+3.5pp
Operating margin-4.4%-1.9pp
Net margin-6.1%-2.5pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-48%-17.5pp
Debt / equity5.7×+2.3×
Current ratio3.2×+0.7×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The source filing: Tandem Diabetes Care’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001438133-26-000125
Line itemSix Months Ended June 30, 2026Six Months Ended June 30, 2025
Net cash provided by (used in) investing activities(282,784)67,316
Financing Activities
Proceeds from issuance of convertible senior notes due 2032, net of $8,843 debt issuance costs291,157
Principal payments on convertible senior notes due 2025(40,760)
Payment for capped call transactions related to convertible senior notes due 2032(15,300)
Cash used to settle withholding taxes on vested restricted stock, net of proceeds from issuance of common stock under Company stock plans458(3,641)
Net cash provided by (used in) financing activities276,315(44,401)
Effect of foreign exchange rate changes on cash2,229(263)

Item 1. Financial Statements.

FAQ

What is Tandem Diabetes Care's debt repayments?
Tandem Diabetes Care (TNDM) reported debt repayments of $40.76M in Q2 2025.
How has Tandem Diabetes Care's debt repayments changed year-over-year?
Tandem Diabetes Care's debt repayments increased by 116.6% year-over-year, from -$246.12M to $40.76M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Ask your AI about Tandem Diabetes Care's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude